Ondansetron Tablet, Orally Disintegrating
Product Images NDC 72336-073

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 72336-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifsa Drugs Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Ondansetron Od Tabs 16mg Bottle Label)

Ondansetron Orally Disintegrating Tablets, USP 16 mg in a 30-tablet package. The label shows product strength (16 mg), dosage form (orally disintegrating tablets), NDC number 72336-073-30, and indicates it is prescription only (Rx only). The labeler is Lifsa Drugs LLC, with storage instructions and a barcode visible.*

FDA Label Image

Image Description (Ondansetron Od Tabs Structure)

Chemical structure of the active ingredient Ondansetron, illustrating its molecular framework including aromatic and heterocyclic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.